Spectral Med Stock Analysis
EDT Stock | CAD 0.53 0.03 6.00% |
Spectral Med is overvalued with Real Value of 0.47 and Hype Value of 0.52. The main objective of Spectral Med stock analysis is to determine its intrinsic value, which is an estimate of what Spectral Med is worth, separate from its market price. There are two main types of Spectral Med's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Spectral Med's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Spectral Med's stock to identify patterns and trends that may indicate its future price movements.
The Spectral Med stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Spectral Med is usually not traded on Canada Day, Civic Holiday, Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. Spectral Stock trading window is adjusted to America/Toronto timezone.
Spectral |
Spectral Stock Analysis Notes
About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.1. Spectral Med last dividend was issued on the 19th of December 2011. Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada. SPECTRAL MEDICAL operates under Diagnostics Research classification in Canada and is traded on Toronto Stock Exchange. It employs 18 people. To learn more about Spectral Med call Christopher Seto at 416 626 3233 or check out https://spectraldx.com.Spectral Med Investment Alerts
Spectral Med generated a negative expected return over the last 90 days | |
Spectral Med has some characteristics of a very speculative penny stock | |
Spectral Med has high historical volatility and very poor performance | |
Spectral Med has a very high chance of going through financial distress in the upcoming years | |
The company reported the revenue of 1.6 M. Net Loss for the year was (15.51 M) with profit before overhead, payroll, taxes, and interest of 983 K. | |
Spectral Med has accumulated about 3.8 M in cash with (11.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
Roughly 18.0% of the company shares are held by company insiders | |
Latest headline from news.google.com: Spectral AIs Military Medical Device Advances with 7.2M Govt Funding, FDA Breakthrough Status MDAI Stock News - StockTitan |
Spectral Largest EPS Surprises
Earnings surprises can significantly impact Spectral Med's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2018-08-14 | 2018-06-30 | -0.01 | -0.0068 | 0.0032 | 32 | ||
2017-08-11 | 2017-06-30 | -0.01 | -0.0054 | 0.0046 | 46 | ||
2017-03-30 | 2016-12-31 | -0.01 | -0.0049 | 0.0051 | 51 |
Spectral Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 149.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Spectral Med's market, we take the total number of its shares issued and multiply it by Spectral Med's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Spectral Profitablity
Spectral Med's profitability indicators refer to fundamental financial ratios that showcase Spectral Med's ability to generate income relative to its revenue or operating costs. If, let's say, Spectral Med is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Spectral Med's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Spectral Med's profitability requires more research than a typical breakdown of Spectral Med's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (3.12) | (2.97) | |
Return On Capital Employed | 2.27 | 2.38 | |
Return On Assets | (3.01) | (2.86) | |
Return On Equity | 0.95 | 0.99 |
Management Efficiency
Spectral Med has return on total asset (ROA) of (0.9322) % which means that it has lost $0.9322 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (9.7397) %, meaning that it generated substantial loss on money invested by shareholders. Spectral Med's management efficiency ratios could be used to measure how well Spectral Med manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Spectral Med's Return On Capital Employed is very stable compared to the past year. As of the 23rd of November 2024, Return On Equity is likely to grow to 0.99, though Return On Tangible Assets are likely to grow to (2.97). At this time, Spectral Med's Debt To Assets are very stable compared to the past year. As of the 23rd of November 2024, Asset Turnover is likely to grow to 0.31, while Total Assets are likely to drop about 5 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | (0.06) | (0.06) | |
Tangible Book Value Per Share | (0.06) | (0.06) | |
Enterprise Value Over EBITDA | (8.89) | (9.33) | |
Price Book Value Ratio | (7.15) | (6.80) | |
Enterprise Value Multiple | (8.89) | (9.33) | |
Price Fair Value | (7.15) | (6.80) | |
Enterprise Value | 124 M | 130.2 M |
Leadership effectiveness at Spectral Med is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (9.46) | Beta 1.004 | Return On Assets (0.93) | Return On Equity (9.74) |
Technical Drivers
As of the 23rd of November, Spectral Med has the Coefficient Of Variation of (1,213), variance of 12.57, and Risk Adjusted Performance of (0.06). Spectral Med technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices.Spectral Med Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Spectral Med middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Spectral Med. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Spectral Med Outstanding Bonds
Spectral Med issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Spectral Med uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Spectral bonds can be classified according to their maturity, which is the date when Spectral Med has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 4875 Corp BondUS55336VAG59 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
International Game Technology Corp BondUS460599AD57 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Spectral Med Predictive Daily Indicators
Spectral Med intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Spectral Med stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Spectral Med Forecast Models
Spectral Med's time-series forecasting models are one of many Spectral Med's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Spectral Med's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Spectral Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Spectral Med prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Spectral shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Spectral Med. By using and applying Spectral Stock analysis, traders can create a robust methodology for identifying Spectral entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (9.70) | (9.22) | |
Operating Profit Margin | (7.15) | (6.79) | |
Net Loss | (9.80) | (9.31) | |
Gross Profit Margin | 0.41 | 0.78 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Spectral Med to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
All Next | Launch Module |
Other Information on Investing in Spectral Stock
Spectral Med financial ratios help investors to determine whether Spectral Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.